# Latigo Biotherapeutics, Inc. Common Stock (LTGO)

> Latigo Biotherapeutics, Inc. Common Stock (LTGO) trades at $13.31 (-3.27%) as of 5:19:44 PM EST on Nov 18, 2026, -12.72% over the past month. Market cap is $882.44M, with 5.4 days to cover in short interest.

Canonical: https://massive.com/quote/ltgo
Data as of: 2026-11-18T22:19:44.976Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$13.31** -0.45 (-3.27%)
As of 5:19:44 PM EST on Nov 18, 2026 · 15-minute delayed
Nasdaq · usd

## Stock performance

How Latigo Biotherapeutics, Inc. Common Stock (LTGO) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -3.27% |
| 1W | -1.55% |
| 1M | -12.72% |
| YTD | -27.07% |
| 1Y | -27.07% |
| 52-wk range | $10.24 – $25.93 |

From daily closes through Nov 18, 2026.

## Key statistics

Today's trading snapshot for LTGO: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $13.21 – $14.26 |
| Open | $14.00 |
| Prev close | $13.76 |
| Volume | 209.1K |
| Market cap | $882.44M |
| Shares out | 66.3M |

## Insider trading

[Latigo Biotherapeutics, Inc. Common Stock (LTGO) insider trading](https://massive.com/quote/ltgo/insider-trading.md): open-market Form 4 buys and sells by Latigo Biotherapeutics, Inc. Common Stock insiders over the last 12 months.

## 8-K filings

Material corporate events Latigo Biotherapeutics, Inc. Common Stock has disclosed to the SEC on Form 8-K.

- Nov 5, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On November 5, 2026, Latigo Biotherapeutics, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended September 30, 2026.”
- Sep 3, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On September 3, 2026, Latigo Biotherapeutics, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended June 30, 2026.”
- Aug 10, 2026 · Public offering
  “On August 10, 2026, the Company completed its IPO of an aggregate of 19,200,000 shares of common stock at a price to the public of $18.00 per share. The aggregate gross proceeds from the IPO, before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company, were approximately $345.6 million.”

## LTGO short interest

How heavily LTGO is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 5.4 |
| Short interest | 941.43K |
| Avg volume | 173.41K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## About Latigo Biotherapeutics, Inc. Common Stock

Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | PHARMACEUTICAL PREPARATIONS |
| IPO | $18.00 on Aug 7, 2026 |

[Latigo Biotherapeutics IPO page](https://massive.com/quote/ltgo/ipo.md)

[Company website](https://www.latigobio.com)

## FAQ

### What is the Latigo Biotherapeutics, Inc. Common Stock (LTGO) stock price today?

Latigo Biotherapeutics, Inc. Common Stock (LTGO) is trading at $13.31 (-3.27% on the day) as of 5:19:44 PM EST on Nov 18, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Latigo Biotherapeutics, Inc. Common Stock?

Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction.

### What is the short interest in LTGO?

As of Oct 30, 2026, LTGO has 941.43K shares short and 5.4 days to cover.

### What exchange is LTGO listed on?

Latigo Biotherapeutics, Inc. Common Stock (LTGO) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

## Live data

Prices here are 15-minute delayed. For real-time LTGO quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=LTGO`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Latigo Biotherapeutics, Inc. Common Stock (LTGO) insider trading](https://massive.com/quote/ltgo/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
